Description of the website
The website of the Global Vaccine Data network is a member of the WHO-led project Vaccine Safety Net (VSN).
The Global Vaccine Data Network is a consortium of research sites ready to conduct globally coordinated epidemiologic studies of the safety of vaccines, including COVID-19 vaccines, as they are introduced. We aim to facilitate collaborative studies of vaccine safety and effectiveness using health data from diverse populations in countries around the world. With international cooperation it is now possible to have a large enough population to conduct robust analyses of rare events following vaccination.
The GVDN website contains descriptions of our goals, the methods we use, and how big data can help assess vaccine safety. It features a list of international partners who participate in our vaccine safety studies, and commentary on topics such as vaccine hesitancy. There is a News & Stories blog page which we update regularly, a Contact form and links to relevant publications and social media. The GVDN is supported by a coordinating centre based at the University of Auckland in New Zealand, where a dashboard that will present the results of our vaccine safety studies is being developed.
Website’s sponsorship policy
The GVDN received seeding money from the Gates foundation in 2019 and relies on research grants for specific vaccine safety monitoring projects. The GVDN recently received significant funding from the US Centers for Disease Control and Prevention for a 3-year project entitled Global Covid Vaccine Safety (GCoVS). The GVDN enjoys support in kind from Auckland UniServices, a wholly owned non-profit subsidiary of the University of Auckland, which has been ranked #1 for two consecutive years in the Impact rankings by Times Higher Education (THE). See About
Website’s content or editorial policy
We guarantee the independence of editorial content from funding sources. Website content, including news items and stories, is selected in consultation with one of the GVDN’s two co-directors and comments are moderated by the epidemiological team at the coordinating centre. See News & Stories.